Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-Issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls
April 24, 2026
April 24, 2026
WASHINGTON, April 24 -- The U.S. Department of Justice issued the following news release on April 23, 2026:
* * *
Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls
The Action Expands Access to Approved Therapies and Supports State-Regulated Medical Marijuana Programs
*
* * *
Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls
The Action Expands Access to Approved Therapies and Supports State-Regulated Medical Marijuana Programs
*
